SPRUCE BIOSCIENCES, INC. (SPRB) Form 8-K — Jul 27, 2026
Spruce Biosciences appointed Adrian Quartel, M.D., FFPM as Chief Medical Officer, replacing Interim CMO Dr. Kirk Ways. Dr. Ways will continue to serve as a member of the Company's Board of Directors.
Price after filing
1 day: -0.9%7 days: +2.7%30 days: +51.0%
Close on the filing date to close N calendar days later (from $41.99). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.